Exforge 10-160 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FJJ9H
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,980
Award facts
- Contract value 100% obligated
- $11,979.79 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded January 22, 2026, by the Defense Logistics Agency to AmerisourceBergen Drug Corp, provides 30-count tablets of Exforge 10-160 mg under a firm fixed-price contract with a ceiling value of $11,979.79. The contract is not set-aside and represents a competitive award. Performance is scheduled for completion by January 23, 2026, with the place of performance located in Conshohocken, Pennsylvania, where AmerisourceBergen's corporate office is headquartered. This delivery order is executed under AmerisourceBergen's parent company, Cencora, Inc., which holds a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031.
The supply of Exforge, an antihypertensive medication combining amlodipine and valsartan, supports the Defense Logistics Agency's mission to supply pharmaceutical products and medical commodities to military healthcare systems globally. As a major pharmaceutical distributor, AmerisourceBergen has demonstrated consistent capability to fulfill federal medical procurement requirements through its extensive portfolio of brand-name and generic medications delivered via firm fixed-price task orders under the DLA Troop Support Medical vehicle. This award reflects the company's ongoing role as a critical vendor for military treatment facilities and federal healthcare programs requiring prescription medications across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FJJ9H?
SPE2DR26FJJ9H was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26FJJ9H worth?
The government has obligated $11,980 on SPE2DR26FJJ9H.
Is contract SPE2DR26FJJ9H an order under another contract?
Yes. SPE2DR26FJJ9H is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJJ9H competed?
The extent of competition for SPE2DR26FJJ9H was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award